Drug shortage woes continue in the UK

INICIO/Noticias Farmacéuticas | Posted 27/01/2012 post-comment0 Post your comment

Despite attempts to solve problems with shortages of brand-name medicines in the UK, the issue is far from beings resolved. The latest news is that the UK’s wholesalers have called for a ‘third-party monitoring and survey service’ to help tackle medicines shortages, while the Association of the British Pharmaceutical Industry (ABPI) is calling for sanctions on pharmacists that act as wholesalers.

picture 77

The British Association of Pharmaceutical Wholesalers (BAPW) has called on pharmacists and manufacturers to support objective monitoring and reporting of brand-name medicine supplies. The association stressed that the introduction of a third-party monitoring and survey service of medicine supplies to pharmacies and dispensing doctors needed ‘urgent consideration’.

The BAPW adds that although the various stakeholders are working together more closely, ‘inefficiencies remain in the supply chain’, which the BAPW feels could be rebalanced by ‘regulatory enforcement’ and ‘adjustment’.

Meanwhile, the ABPI are calling for the legal separation of pharmacies’ wholesaling and dispensing activities to ensure patients ‘get priority’ when medicines are in short supply according to Chemist+Druggist. The ABPI believe that separating the activities would ensure pharmacists put patients before business.

Currently in the UK there are 1,800 wholesaler licences, which enable pharmacists to export medicines for profit, possibly exacerbating drug shortages. The UK medicines authority–Medicines and Healthcare products Regulatory Agency–has already stated that pharmacists with ‘unusual purchasing patterns’ could face investigation over their exporting businesses.

The views of the APBI and BAPW are expected to be presented at the first oral evidence session of the All-Party Pharmacy Group’s (APPG’s) Inquiry into medicine shortages, which was scheduled at the House of Commons on 24 January 2012.

Related articles

UK drug shortages are far from being solved

UK drug shortages continue to affect pharmacists and patients

Source: BAPW, Chemist+Druggist

comment icon Comments (0)
Post your comment
Related content
El recorrido del biológico de continuación Pectuna (pertuzumab) en Irán
Cancer Cell V13I20
INICIO/Noticias Farmacéuticas Posted 29/02/2024
Fiocruz y Pfizer firman un acuerdo para el genérico de Xeljanz
Remicade V13F28
INICIO/Noticias Farmacéuticas Posted 30/01/2024
Genfar: La nueva marca de genéricos de Eurofarma en América Latina
10 AA008993
INICIO/Noticias Farmacéuticas Posted 12/12/2023
Most viewed articles
Sobre GaBI
INICIO/Sobre GaBI Posted 06/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
INICIO/Directrices Posted 08/10/2010